X-linked hypohidrotic ectodermal dysplasia (XLHED, Christ-Siemens-Touraine syndrome) is an X-linked recessive disorder caused by loss-of-function mutations in the EDA gene, which encodes ectodysplasin A, a TNF superfamily ligand. The EDA/EDAR/NF-kappaB signaling pathway is essential for the initiation and morphogenesis of ectodermal appendages including hair follicles, teeth, and eccrine sweat glands. Affected males present with the classic triad of hypohidrosis (reduced sweating due to absent or hypoplastic eccrine glands), hypotrichosis (sparse scalp and body hair), and hypodontia/oligodontia with conical teeth. Carrier females may show mild, mosaic features due to random X-inactivation. The reduced ability to sweat creates life-threatening hyperthermia risk, especially in infancy. Characteristic facial features include frontal bossing, depressed nasal bridge, periorbital hyperpigmentation, and prominent lips. The prevalence of HED is approximately 1 per 100,000, and XLHED is the most common form.
Ask a research question about X-linked Hypohidrotic Ectodermal Dysplasia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: X-linked Hypohidrotic Ectodermal Dysplasia
creation_date: "2026-04-24T00:00:00Z"
updated_date: "2026-04-24T00:00:00Z"
description: >-
X-linked hypohidrotic ectodermal dysplasia (XLHED, Christ-Siemens-Touraine syndrome)
is an X-linked recessive disorder caused by loss-of-function mutations in the EDA gene,
which encodes ectodysplasin A, a TNF superfamily ligand. The EDA/EDAR/NF-kappaB signaling
pathway is essential for the initiation and morphogenesis of ectodermal appendages including
hair follicles, teeth, and eccrine sweat glands. Affected males present with the classic triad
of hypohidrosis (reduced sweating due to absent or hypoplastic eccrine glands), hypotrichosis
(sparse scalp and body hair), and hypodontia/oligodontia with conical teeth. Carrier females
may show mild, mosaic features due to random X-inactivation. The reduced ability to sweat
creates life-threatening hyperthermia risk, especially in infancy. Characteristic facial
features include frontal bossing, depressed nasal bridge, periorbital hyperpigmentation,
and prominent lips. The prevalence of HED is approximately 1 per 100,000, and XLHED is the
most common form.
category: Genetic
parents:
- Ectodermal Dysplasia
disease_term:
preferred_term: X-linked hypohidrotic ectodermal dysplasia
term:
id: MONDO:0010585
label: X-linked hypohidrotic ectodermal dysplasia
inheritance:
- name: X-linked Recessive
inheritance_term:
preferred_term: X-linked recessive inheritance
term:
id: HP:0001419
label: X-linked recessive inheritance
evidence:
- reference: PMID:29855039
reference_title: "Hypohidrotic ectodermal dysplasia: clinical and molecular review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Although there are autosomal recessive and dominant forms, X-linked (XL)
is the most frequent form of the disease.
explanation: >-
Confirms X-linked as the most common inheritance pattern for HED.
pathophysiology:
- name: EDA/EDAR/NF-kappaB Signaling Deficiency
description: >-
Loss-of-function mutations in EDA abolish functional ectodysplasin A, a type II
transmembrane protein of the TNF superfamily. EDA is cleaved to a soluble form that
binds its receptor EDAR, activating the adaptor EDARADD and the downstream NF-kappaB
pathway. This core signaling cascade relies on NF-kappaB pathway activation to regulate
target genes involved in Wnt, Shh, FGF, and TGF-beta pathways that control interactions
between epithelial and mesenchymal cells during ectodermal appendage development.
Without EDA signaling, ectodermal placodes fail to form or differentiate properly,
resulting in absent or hypoplastic hair follicles, teeth, and sweat glands.
cell_types:
- preferred_term: keratinocyte
term:
id: CL:0000312
label: keratinocyte
- preferred_term: eccrine cell
term:
id: CL:0000434
label: eccrine cell
biological_processes:
- preferred_term: ectodermal placode formation
term:
id: GO:0060788
label: ectodermal placode formation
modifier: DECREASED
- preferred_term: canonical NF-kappaB signal transduction
term:
id: GO:0007249
label: canonical NF-kappaB signal transduction
modifier: DECREASED
evidence:
- reference: PMID:24070496
reference_title: "The ectodysplasin pathway: from diseases to adaptations."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It comprises three main gene products: EDA, a ligand that belongs to the tumor
necrosis factor (TNF)-α family, EDAR, a receptor related to the TNFα receptors,
and EDARADD, a specific adaptor. This core pathway relies on downstream NF-κB
pathway activation to regulate target genes.
explanation: >-
Review of EDA pathway biology across vertebrate species describing the
EDA-EDAR-EDARADD-NF-kappaB signaling cascade.
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
The EDA-EDAR system is an important effector of canonical Wnt signalling in
developing skin appendages. It functions by stimulating NF-κB-mediated
transcription of effectors or inhibitors of the Wnt, Sonic hedgehog (SHH),
fibroblast growth factor (FGF) and transforming growth factor beta (TGFβ)
pathways that regulate interactions within or between epithelial and mesenchymal
cells and tissues.
explanation: >-
Details the downstream signaling pathways regulated by EDA-EDAR-NF-kappaB,
established primarily in animal models of Eda deficiency.
downstream:
- target: Eccrine Sweat Gland Aplasia/Hypoplasia
- target: Hair Follicle Developmental Failure
- target: Tooth Developmental Defects
- target: Mucosal Gland Aplasia/Hypoplasia
- name: Eccrine Sweat Gland Aplasia/Hypoplasia
description: >-
Absence of EDA signaling during embryogenesis prevents normal eccrine sweat gland
development. Affected males have markedly reduced or absent eccrine glands, leading to
severe hypohidrosis. The inability to thermoregulate through sweating causes
life-threatening hyperthermia, particularly in infants and young children.
cell_types:
- preferred_term: eccrine cell
term:
id: CL:0000434
label: eccrine cell
biological_processes:
- preferred_term: sweat gland development
term:
id: GO:0060792
label: sweat gland development
modifier: DECREASED
evidence:
- reference: PMID:29694819
reference_title: "Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Genetic deficiency of ectodysplasin A (EDA) causes X-linked hypohidrotic
ectodermal dysplasia (XLHED), in which the development of sweat glands is
irreversibly impaired, an condition that can lead to life-threatening hyperthermia.
explanation: >-
Establishes that EDA deficiency irreversibly impairs sweat gland development,
causing life-threatening hyperthermia.
downstream:
- target: Hyperthermia Risk
- name: Hair Follicle Developmental Failure
description: >-
Deficient EDA/EDAR signaling impairs hair follicle initiation and development,
resulting in sparse, thin, and slowly growing scalp and body hair. Hair follicle
density is markedly reduced. Eyebrows and eyelashes are also sparse or absent.
biological_processes:
- preferred_term: hair follicle development
term:
id: GO:0001942
label: hair follicle development
modifier: DECREASED
evidence:
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
The TNF family ligand ectodysplasin A (EDA) regulates the induction,
morphogenesis and/or maintenance of skin-derived structures such as teeth,
hair, sweat glands and several other glands.
explanation: >-
Confirms EDA role in development of hair and other skin-derived structures,
established primarily in animal models.
- name: Tooth Developmental Defects
description: >-
EDA signaling is required for tooth morphogenesis. Loss of EDA function leads to
oligodontia (congenitally missing teeth) and characteristic conical (peg-shaped)
teeth in both primary and permanent dentitions. The enamel knot signaling center
depends on Eda-NF-kappaB pathway activity for cusp patterning.
biological_processes:
- preferred_term: odontogenesis of dentin-containing tooth
term:
id: GO:0042475
label: odontogenesis of dentin-containing tooth
modifier: DECREASED
evidence:
- reference: PMID:22421994
reference_title: "Orofacial features of hypohidrotic ectodermal dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypohidrotic ectodermal dysplasia (HED) is a type of genodermatosis
characterized by the abnormal development of sweat glands, teeth, and hair.
explanation: >-
Confirms dental abnormalities as a key feature of HED.
- name: Mucosal Gland Aplasia/Hypoplasia
description: >-
EDA/EDAR signaling is required for the development of secretory glands
throughout the respiratory and gastrointestinal tracts. Deficiency leads to
reduced or absent mucosal and submucosal glands in the airways, impairing
mucociliary clearance and host defense, resulting in chronic nasal congestion,
sinusitis, recurrent pulmonary infections, and hoarse voice.
biological_processes:
- preferred_term: gland development
term:
id: GO:0048732
label: gland development
modifier: DECREASED
downstream:
- target: Recurrent Respiratory Infections
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
the registry dataset confirmed a spectrum of life-long XLHED clinical
complications including recurrent sinus infections (49% males, 52% females),
nasal congestion often foul smelling and interfering with feeding (73% males,
27% females)
explanation: >-
Registry data documenting the high prevalence of respiratory and nasal
complications reflecting mucosal gland deficiency.
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
susceptibility to airways infections and crusting of various secretions.
explanation: >-
Airway infection susceptibility and secretion crusting reflect mucosal
gland hypoplasia from deficient EDA signaling.
- name: Hyperthermia Risk
description: >-
The absence of functional eccrine sweat glands renders affected individuals unable to
dissipate heat through evaporative cooling. This creates a risk of life-threatening
hyperthermia, especially during febrile illness, exercise, or hot weather. Unexplained
fevers in infancy may be the presenting sign.
evidence:
- reference: PMID:24928340
reference_title: "Ectodysplasin research--where to next?"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In humans, HED is a life-threatening condition in particular in infants due to
absent or severely reduced sweating leading to hyperthermia.
explanation: >-
Confirms the life-threatening nature of hyperthermia in HED, especially in infants.
- reference: PMID:24678015
reference_title: "Future developments in XLHED treatment approaches."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first years of life, XLHED-affected patients are at risk for
life-threatening hyperthermia and pulmonary infection.
explanation: >-
Confirms hyperthermia risk is greatest in early childhood.
phenotypes:
- name: Hypohidrosis
category: Classic
description: >-
Reduced or absent sweating due to aplasia or severe hypoplasia of eccrine sweat glands.
This is the most clinically significant feature due to associated hyperthermia risk.
Reported in 89% of XLHED registrants in the EDIR international registry.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Hypohidrosis
term:
id: HP:0000966
label: Hypohidrosis
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
XLHED is diagnosed by the triad of decreased sweating, reduced hair, and
hypodontia (present in 89%, 74%, and 74% of XLHED respondents).
explanation: >-
International registry data showing decreased sweating in 89% of XLHED respondents.
- reference: PMID:19681132
reference_title: "Molecular aspects of hypohidrotic ectodermal dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypohidrotic (anhidrotic) ectodermal dysplasia (HED) is a congenital syndrome
characterized by sparse hair, oligodontia, and reduced sweating.
explanation: >-
Identifies reduced sweating as one of the three cardinal features of HED.
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
HED (also known as Christ-Siemens-Touraine syndrome) is characterized by
hypohidrosis (reduced ability to sweat), hypotrichosis (sparseness of scalp and
body hair), and hypodontia (congenital absence of teeth)
explanation: >-
Confirms hypohidrosis as part of the classic clinical triad.
- name: Sparse Hair
category: Classic
description: >-
Thin, sparse, light-colored scalp hair with reduced hair follicle density. Body hair
is similarly sparse or absent. Reported in 74% of XLHED registrants.
frequency: FREQUENT
phenotype_term:
preferred_term: Sparse hair
term:
id: HP:0008070
label: Sparse hair
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
XLHED is diagnosed by the triad of decreased sweating, reduced hair, and
hypodontia (present in 89%, 74%, and 74% of XLHED respondents).
explanation: >-
Registry data showing reduced hair in 74% of respondents.
- reference: PMID:19681132
reference_title: "Molecular aspects of hypohidrotic ectodermal dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypohidrotic (anhidrotic) ectodermal dysplasia (HED) is a congenital syndrome
characterized by sparse hair, oligodontia, and reduced sweating.
explanation: >-
Sparse hair is identified as one of the three cardinal features of HED.
- name: Oligodontia
category: Classic
description: >-
Congenital absence of six or more permanent teeth. Both primary and permanent
dentitions are affected with characteristic conical (peg-shaped) morphology
of remaining teeth. Reported in 74% of XLHED registrants.
frequency: FREQUENT
phenotype_term:
preferred_term: Oligodontia
term:
id: HP:0000677
label: Oligodontia
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
XLHED is diagnosed by the triad of decreased sweating, reduced hair, and
hypodontia (present in 89%, 74%, and 74% of XLHED respondents).
explanation: >-
Registry data showing hypodontia in 74% of respondents.
- reference: PMID:19681132
reference_title: "Molecular aspects of hypohidrotic ectodermal dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypohidrotic (anhidrotic) ectodermal dysplasia (HED) is a congenital syndrome
characterized by sparse hair, oligodontia, and reduced sweating.
explanation: >-
Oligodontia is identified as one of the three cardinal features of HED.
- name: Conical Teeth
category: Classic
description: >-
Remaining teeth exhibit a characteristic conical or peg-shaped morphology,
especially the incisors and canines.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Conical tooth
term:
id: HP:0000698
label: Conical tooth
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The male patients with the mutation in this family all have very typical HED
facial features, with clinical characteristics of hypotrichosis, hypodontia,
hypohidrosis, and partial peg-shaped teeth
explanation: >-
Confirms peg-shaped (conical) teeth as a characteristic feature in affected males.
- name: Heat Intolerance
category: Classic
description: >-
Inability to tolerate warm environments due to defective thermoregulation
from absent eccrine glands. Can lead to life-threatening hyperthermia.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Heat intolerance
term:
id: HP:0002046
label: Heat intolerance
evidence:
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This syndrome is characterized by the absence or malformation of several
skin-derived appendages resulting in hypotrychosis, hypodontia,
heat-intolerance, dry skin and dry eyes
explanation: >-
Heat intolerance listed as a defining feature of HED.
- name: Nasal Congestion
category: Respiratory
description: >-
Chronic nasal congestion, often foul smelling and interfering with feeding in
infancy. Reflects mucosal gland hypoplasia in the nasal passages. Reported in
73% of males and 27% of females in the EDIR registry.
frequency: FREQUENT
phenotype_term:
preferred_term: Nasal congestion
term:
id: HP:0001742
label: Nasal congestion
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
nasal congestion often foul smelling and interfering with feeding (73% males,
27% females)
explanation: >-
Registry data quantifying nasal congestion frequency in XLHED.
- name: Wheezing
category: Respiratory
description: >-
Recurrent wheezing episodes reflecting airway gland hypoplasia and impaired
mucociliary clearance. Reported in 66% of males and 45% of females in the
EDIR registry.
frequency: FREQUENT
phenotype_term:
preferred_term: Wheezing
term:
id: HP:0030828
label: Wheezing
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
wheezing (66% males, 45% females)
explanation: >-
Registry data quantifying wheezing frequency in XLHED.
- name: Hoarse Voice
category: Respiratory
description: >-
Hoarse or raspy voice due to laryngeal gland hypoplasia and reduced
mucosal secretions. Reported in 67% of males and 23% of females in the
EDIR registry.
frequency: FREQUENT
phenotype_term:
preferred_term: Hoarse voice
term:
id: HP:0001609
label: Hoarse voice
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
a hoarse, raspy voice (67% males, 23% females)
explanation: >-
Registry data quantifying hoarse voice frequency in XLHED.
- name: Dry Skin
category: Dermatologic
description: >-
Xerosis due to reduced eccrine and sebaceous gland function. The skin may appear
thin and finely wrinkled, particularly around the eyes.
frequency: FREQUENT
phenotype_term:
preferred_term: Dry skin
term:
id: HP:0000958
label: Dry skin
evidence:
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This syndrome is characterized by the absence or malformation of several
skin-derived appendages resulting in hypotrychosis, hypodontia,
heat-intolerance, dry skin and dry eyes
explanation: >-
Dry skin identified as a characteristic feature of HED.
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinical characteristics included dry skin, decreased sweating, sparse hair,
missing teeth, frontal bossing, prominent lips, periorbital wrinkling, and
presenile manifestations. He was intolerant to heat.
explanation: >-
Clinical description from a 4-year-old patient confirming dry skin.
- name: Frontal Bossing
category: Craniofacial
description: >-
Prominent forehead contributing to the characteristic facies of XLHED.
frequency: FREQUENT
phenotype_term:
preferred_term: Frontal bossing
term:
id: HP:0002007
label: Frontal bossing
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Homozygous male patients usually have typical clinical manifestations of
hypodontia, hypohidrosis, and sparse hair and characteristic facial features
including frontal bossing, chin prominence, saddle nose, wrinkles, low-set
ears, maxillary hypoplasia, and periorbital hyperpigmentation
explanation: >-
Frontal bossing identified as a characteristic facial feature of XLHED.
- name: Depressed Nasal Bridge
category: Craniofacial
description: >-
Flattened or depressed nasal bridge (saddle nose), a characteristic facial feature.
frequency: FREQUENT
phenotype_term:
preferred_term: Depressed nasal bridge
term:
id: HP:0005280
label: Depressed nasal bridge
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
characteristic facial features including frontal bossing, chin prominence,
saddle nose, wrinkles, low-set ears, maxillary hypoplasia, and periorbital
hyperpigmentation
explanation: >-
Saddle nose (depressed nasal bridge) is a recognized facial feature.
- name: Periorbital Hyperpigmentation
category: Craniofacial
description: >-
Dark circles around the eyes with fine wrinkling of periorbital skin.
frequency: FREQUENT
phenotype_term:
preferred_term: Periorbital hyperpigmentation
term:
id: HP:0001106
label: Periorbital hyperpigmentation
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
characteristic facial features including frontal bossing, chin prominence,
saddle nose, wrinkles, low-set ears, maxillary hypoplasia, and periorbital
hyperpigmentation
explanation: >-
Periorbital hyperpigmentation is listed among the characteristic facial features.
- name: Everted Lower Lip
category: Craniofacial
description: >-
Prominent, everted lower lip vermilion contributing to the characteristic facial
appearance.
frequency: FREQUENT
phenotype_term:
preferred_term: Everted lower lip vermilion
term:
id: HP:0000232
label: Everted lower lip vermilion
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinical characteristics included dry skin, decreased sweating, sparse hair,
missing teeth, frontal bossing, prominent lips, periorbital wrinkling, and
presenile manifestations.
explanation: >-
Prominent lips identified in clinical description of affected patient.
- name: Sparse Eyebrows
category: Craniofacial
description: >-
Reduced or absent eyebrow hair.
phenotype_term:
preferred_term: Sparse eyebrow
term:
id: HP:0045075
label: Sparse eyebrow
- name: Recurrent Respiratory Infections
category: Respiratory
description: >-
Increased susceptibility to respiratory tract infections due to reduced
submucosal gland secretions in the upper and lower airways, leading to
impaired mucociliary clearance. Registry data report recurrent sinus infections
in 49% of males and infections requiring antibiotics in 52%.
frequency: FREQUENT
phenotype_term:
preferred_term: Recurrent respiratory infections
term:
id: HP:0002205
label: Recurrent respiratory infections
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
the registry dataset confirmed a spectrum of life-long XLHED clinical
complications including recurrent sinus infections (49% males, 52% females),
nasal congestion often foul smelling and interfering with feeding (73% males,
27% females)
explanation: >-
International registry quantifying respiratory complications in XLHED.
- reference: PMID:24678015
reference_title: "Future developments in XLHED treatment approaches."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first years of life, XLHED-affected patients are at risk for
life-threatening hyperthermia and pulmonary infection. Survival into childhood
and beyond is associated with severe dental abnormalities as well as chronic
growth, respiratory, skin, eye, and psychosocial disorders.
explanation: >-
Pulmonary infection risk and chronic respiratory disorders are recognized
features of XLHED.
- name: Eczematoid Dermatitis
category: Dermatologic
description: >-
Eczema or atopic dermatitis can occur, possibly related to impaired skin barrier
function from reduced sweat and sebaceous gland activity. Reported in 66% of
males and 40% of females in the international XLHED registry.
frequency: FREQUENT
phenotype_term:
preferred_term: Eczematoid dermatitis
term:
id: HP:0000964
label: Eczematoid dermatitis
evidence:
- reference: PMID:24664614
reference_title: "X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
eczema (66% males, 40% females)
explanation: >-
Registry data quantifying eczema frequency in XLHED.
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
HED can also be complicated with atopic diathesis (hypohidrosis or anhidrosis
itself might impair the skin barrier)
explanation: >-
Eczema/atopic dermatitis recognized as a complication of HED related to
impaired skin barrier from absent sweat glands.
- name: Dry Eyes
category: Ophthalmologic
description: >-
Reduced tear production and dry eyes due to deficient lacrimal and meibomian gland
development.
phenotype_term:
preferred_term: Keratoconjunctivitis sicca
term:
id: HP:0001097
label: Keratoconjunctivitis sicca
evidence:
- reference: PMID:24508088
reference_title: "Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
hypotrychosis, hypodontia, heat-intolerance, dry skin and dry eyes,
susceptibility to airways infections and crusting of various secretions.
explanation: >-
Dry eyes listed as a recognized feature of HED.
- name: Nail Dysplasia
category: Dermatologic
description: >-
Nails may be thin, brittle, or ridged.
phenotype_term:
preferred_term: Nail dysplasia
term:
id: HP:0002164
label: Nail dysplasia
- name: Periorbital Wrinkling
category: Craniofacial
description: >-
Fine wrinkling of the periorbital skin, contributing to a prematurely aged
appearance around the eyes.
frequency: FREQUENT
phenotype_term:
preferred_term: Periorbital wrinkles
term:
id: HP:0000607
label: Periorbital wrinkles
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinical characteristics included dry skin, decreased sweating, sparse hair,
missing teeth, frontal bossing, prominent lips, periorbital wrinkling, and
presenile manifestations.
explanation: >-
Periorbital wrinkling identified in clinical description of affected patient.
genetic:
- name: EDA Loss-of-Function Mutations
gene_term:
preferred_term: EDA
term:
id: hgnc:3157
label: EDA
association: Causative
inheritance:
- name: X-linked Recessive
inheritance_term:
preferred_term: X-linked recessive inheritance
term:
id: HP:0001419
label: X-linked recessive inheritance
notes: >-
XLHED is caused by hemizygous loss-of-function mutations in the EDA gene on Xq13.1.
EDA encodes ectodysplasin A, a type II transmembrane protein of the TNF superfamily.
In a literature review, 83.8% of HED mutations were in EDA, 11.8% in EDAR, and
2.9% in EDARADD, confirming EDA mutations are by far the most common cause. Mutations
include missense, nonsense, splice site, and deletion types, predominantly affecting
the collagen-like domain and TNF homology domain.
evidence:
- reference: PMID:29855039
reference_title: "Hypohidrotic ectodermal dysplasia: clinical and molecular review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This XL-HED phenotype is associated with mutations in the gene encoding the
transmembrane protein ectodysplasin-1 (EDA1), a member of the TNFα-related
signaling pathway. The proteins from this pathway are involved in signal
transduction from ectoderm to mesenchyme leading to the development of
ectoderm-derived structures in the fetus such as hair, teeth, skin, nails, and
eccrine sweat glands.
explanation: >-
Identifies EDA1 as the causative gene encoding a TNF-family protein essential
for ectodermal appendage development.
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The review of published papers revealed 68 novel mutations related to HED:
57 (83.8%) were EDA mutations, 8 (11.8%) were EDAR mutations, 2 (2.9%) were
EDARADD mutations
explanation: >-
Literature review quantifying that EDA mutations account for the vast majority
(83.8%) of HED cases.
variants:
- name: Missense mutations in TNF homology domain
description: >-
Mutations disrupting the TNF homology domain prevent proper folding,
trimerization, or EDAR binding.
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Genotype-phenotype correlation analysis revealed that patients with EDA
missense mutations had a higher frequency of hypohidrosis (P = 0.021).
explanation: >-
Genotype-phenotype correlation showing EDA missense mutations associate
with more severe hypohidrosis.
- name: Collagen domain deletions
description: >-
Deletions within the Gly-X-Y repeat collagen-like domain impair
multimerization of EDA.
evidence:
- reference: PMID:32117440
reference_title: "Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
31 (45.6%) were missense mutations, 23 (33.8%) were deletion mutations,
and 1 (1.5%) was an indel.
explanation: >-
Deletion mutations constitute a significant proportion (33.8%) of reported
EDA mutations.
treatments:
- name: Avoidance of Hyperthermia
description: >-
Environmental modifications to prevent overheating, including cooling vests,
air conditioning, avoidance of prolonged sun exposure, and monitoring during
physical activity or febrile illness. This is critical in infancy when
hyperthermia risk is greatest.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
evidence:
- reference: PMID:24678015
reference_title: "Future developments in XLHED treatment approaches."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first years of life, XLHED-affected patients are at risk for
life-threatening hyperthermia and pulmonary infection.
explanation: >-
Establishes the clinical rationale for hyperthermia prevention as a
life-saving intervention.
- name: Dental Prosthetics and Implants
description: >-
Early prosthetic dental rehabilitation with removable dentures in childhood,
transitioning to dental implants in adolescence/adulthood. Addresses both
functional (mastication, speech) and aesthetic concerns.
treatment_term:
preferred_term: dental implantation
term:
id: MAXO:0001534
label: dental implantation
evidence:
- reference: PMID:24678015
reference_title: "Future developments in XLHED treatment approaches."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Survival into childhood and beyond is associated with severe dental
abnormalities as well as chronic growth, respiratory, skin, eye, and
psychosocial disorders.
explanation: >-
Dental abnormalities are a major source of morbidity requiring prosthetic
intervention.
- name: Prenatal EDA1 Replacement Therapy
description: >-
Intra-amniotic administration of recombinant EDA1 replacement protein (Fc-EDA)
during the second trimester can permanently correct sweat gland development.
In treated infants, normal sweating ability was restored and persisted for at
least six years. Postnatal administration was ineffective, indicating a narrow
developmental window.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
evidence:
- reference: PMID:29694819
reference_title: "Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We administered this protein intraamniotically to two affected human twins
at gestational weeks 26 and 31 and to a single affected human fetus at
gestational week 26; the infants, born in week 33 (twins) and week 39
(singleton), were able to sweat normally, and XLHED-related illness had not
developed by 14 to 22 months of age.
explanation: >-
Landmark NEJM study demonstrating successful prenatal correction of XLHED
sweat gland deficiency by intra-amniotic EDA1 replacement.
- reference: PMID:37108325
reference_title: "A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
prenatal EDA1 replacement resulted in ample sweat gland development and
pilocarpine-inducible sweating in all treated subjects, who also attained more
permanent teeth than their untreated affected relatives. Normal perspiration
has persisted for six years in the two oldest boys treated repeatedly with
Fc-EDA in utero.
explanation: >-
Long-term follow-up confirming permanent correction of sweating ability
after prenatal EDA1 replacement, with additional dental benefit.
- name: Genetic Counseling
description: >-
X-linked recessive inheritance counseling for families. Carrier females
have a 50% chance of affected sons. Carrier detection and prenatal/preimplantation
genetic testing are available. Female carriers may exhibit mild features.
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
evidence:
- reference: PMID:22421994
reference_title: "Orofacial features of hypohidrotic ectodermal dysplasia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The identification of female carriers results in genetic counseling being
offered to affected families, as well as providing adequate treatment as
necessary and long-term follow-up of these patients.
explanation: >-
Emphasizes the importance of carrier identification and genetic counseling
for XLHED families.
clinical_trials:
- name: NCT04980638
phase: PHASE_II
status: RECRUITING
description: >-
EDELIFE trial: prospective, open-label, genotype-match controlled,
multicenter Phase 2 trial investigating efficacy and safety of intra-amniotic
ER004 (next-generation EDA1 replacement) as prenatal treatment for male
subjects with XLHED. Three intra-amniotic injections starting at gestational
week 26.
target_phenotypes:
- preferred_term: Hypohidrosis
term:
id: HP:0000966
label: Hypohidrosis
evidence:
- reference: clinicaltrials:NCT04980638
supports: SUPPORT
snippet: >-
This is an open-label, prospective, genotype-match controlled for primary
estimand, non randomized, multicenter, international Phase 2 clinical trial
designed to investigate the efficacy and safety of ER004 administered
intraamniotically as a treatment for unborn XLHED male subjects.
explanation: >-
Ongoing phase 2 trial of prenatal ER004 for XLHED, building on the
successful compassionate-use Fc-EDA experience.
datasets: []
X-linked hypohidrotic ectodermal dysplasia (XLHED) is a rare developmental genetic disorder classically defined by the triad of hypotrichosis, hypohidrosis/anhidrosis, and hypodontia/oligodontia, reflecting abnormal formation of ectodermal appendages (hair follicles, eccrine sweat glands, teeth) due to deficiency of ectodysplasin A1 (EDA1) signaling. (aftab2023xlinkedhypohidroticectodermal pages 1-2, callea2022extendedoverviewof pages 2-4)
A key 2024 advance is improved molecular diagnostic strategy evidence supporting phenotype-guided targeted sequencing (EDA/EDAR) for “classical triad” presentations and exome-scale testing for atypical cases, with copy-number variation (CNV) detection as an important contributor to missed diagnoses. (kim2024geneticprofilingand pages 1-2, kim2024geneticprofilingand pages 7-8)
A major translational development is prenatal protein replacement for affected male fetuses using intra-amniotic delivery of an EDA1 replacement (Fc-EDA/EDI200; and a next-generation molecule ER004), with human compassionate-use data showing sustained restoration of sweating and ongoing multicenter trials (EDELIFE, NCT04980638). (schneider2018prenatalcorrectionof pages 3-5, NCT04980638 chunk 1)
XLHED is a genetic ectodermal dysplasia in which deficiency of ectodysplasin A (EDA/EDA1) signaling disrupts epithelial–mesenchymal interactions required for appendage development, producing reduced/absent sweat glands (heat intolerance, risk of hyperthermia), sparse hair, and missing/abnormal teeth; additional recurrent respiratory, skin, and ocular complications are common. (aftab2023xlinkedhypohidroticectodermal pages 1-2, fete2014x‐linkedhypohidroticectodermal pages 2-4)
Abstract-supported definition (direct quote): XLHED is “diagnosed by the triad of decreased sweating, reduced hair, and hypodontia.” (fete2014x‐linkedhypohidroticectodermal pages 1-2)
| Disease name | Common synonyms / alternative names | MONDO | OMIM/MIM disease # | Causal gene OMIM IDs | ICD-10 | MeSH mapping noted in ClinicalTrials.gov |
|---|---|---|---|---|---|---|
| X-linked hypohidrotic ectodermal dysplasia (XLHED) | Christ-Siemens-Touraine syndrome; X-linked HED; anhidrotic/hypohidrotic ectodermal dysplasia (aftab2023xlinkedhypohidroticectodermal pages 1-2, callea2022extendedoverviewof pages 2-4, fete2014x‐linkedhypohidroticectodermal pages 1-2) | MONDO:0010585 / MONDO_0010585 (NCT04980638 chunk 2) | MIM/OMIM: 305100 (nguyennielsen2013theprevalenceof pages 1-2, callea2022extendedoverviewof pages 2-4, schneider2018prenatalcorrectionof pages 1-2) | EDA: MIM 300451; EDAR: MIM 604095; EDARADD: MIM 606603 (nguyennielsen2013theprevalenceof pages 1-2, callea2022extendedoverviewof pages 2-4) | Q82.4 “Ectodermal Dysplasia (Anhidrotic)” used in Danish registry study for clinically diagnosed HED/XLHED ascertainment (nguyennielsen2013theprevalenceof pages 1-2, nguyennielsen2013theprevalenceof pages 2-3) | “Ectodermal Dysplasia 1, Anhidrotic” (MeSH D053358) in NCT04980638 / EDELIFE record (NCT04980638 chunk 2) |
Table: This table compiles the main nomenclature and database identifiers for X-linked hypohidrotic ectodermal dysplasia, including disease and gene OMIM numbers, MONDO, ICD-10, and MeSH. It is useful for harmonizing disease records across clinical, ontology, and literature sources.
Evidence source type note: identifiers are derived from aggregated disease resources (registry-based epidemiology and patient registries), and trial registries (ClinicalTrials.gov), rather than individual EHR-only sources. (nguyennielsen2013theprevalenceof pages 1-2, fete2014x‐linkedhypohidroticectodermal pages 1-2, NCT04980638 chunk 1)
Primary cause: pathogenic loss-of-function variants in EDA (ectodysplasin A; EDA1 isoform) causing deficiency of EDA1 signaling, inherited in an X-linked manner in XLHED. (schneider2022ectodermaldysplasiasnew pages 1-2, nguyennielsen2013theprevalenceof pages 1-2)
Related hypohidrotic ectodermal dysplasia genes (non-X-linked forms): EDAR, EDARADD, WNT10A are frequently implicated in hypohidrotic ED broadly (with EDAR/EDARADD capable of dominant or recessive forms; WNT10A often recessive). (aftab2023xlinkedhypohidroticectodermal pages 1-2, kovalskaia2023molecularbasisand pages 1-2)
The principal risk factor is carriage of a pathogenic EDA variant in a family (X-linked inheritance), with males generally more severely affected and females showing variable expressivity. (aftab2023xlinkedhypohidroticectodermal pages 1-2, fete2014x‐linkedhypohidroticectodermal pages 2-4)
No specific genetic or environmental protective factors were identified in the retrieved primary sources.
Direct gene–environment interaction evidence (formal GxE) was not identified in the retrieved sources. Clinically, environmental heat exposure interacts with anhidrosis to precipitate hyperthermia risk (a clinically important interaction, though not studied as GxE). (schneider2018prenatalcorrectionof pages 1-2, nguyennielsen2013theprevalenceof pages 1-2)
Below are major phenotypes (symptoms/signs) with suggested HPO terms and evidence.
1) Hypohidrosis/anhidrosis and heat intolerance - Type: clinical sign/functional deficit - Onset: typically infancy/early childhood (early clinical recognition), though diagnosis may be delayed. (nguyennielsen2013theprevalenceof pages 1-2, aftab2023xlinkedhypohidroticectodermal pages 1-2) - Severity: ranges from absent sweating to low residual sweating depending on genotype. (schneider2011sweatingabilityand pages 5-10) - Key complications: life-threatening hyperthermia. (schneider2018prenatalcorrectionof pages 1-2) - Suggested HPO: HP:0000973 (Anhidrosis), HP:0003214 (Hypohidrosis), HP:0002044 (Hyperthermia), HP:0004370 (Heat intolerance) - Quantitative biomarker data (sweat testing): in controls, mean pilocarpine-stimulated sweat volume was 72 µL (range 29–93 µL) and mean sweat pore density 455 pores/cm² (294–900). In XLHED males, 14/31 had no pores/no inducible sweating; 7/31 produced 1–11 µL (low sweating). (schneider2011sweatingabilityand pages 5-10, schneider2011sweatingabilityand pages 1-5)
2) Hypodontia/oligodontia (abnormal or missing teeth) - Type: physical manifestation - Onset: developmental (childhood; detection with tooth development) - Frequency (registry-reported): hypodontia reported in 89% overall of XLHED respondents in EDIR, and in 74% of male XLHED registrants in one registry analysis. (fete2014x‐linkedhypohidroticectodermal pages 1-2) - Suggested HPO: HP:0000668 (Hypodontia), HP:0000674 (Oligodontia), HP:0006480 (Abnormality of dental morphology)
3) Hypotrichosis / sparse scalp hair and eyebrows - Type: physical manifestation - Frequency (registry-reported): reduced hair reported in 74% overall in EDIR and 80% of male XLHED registrants; in females, hair abnormalities still reported by the majority (63% in EDIR). (fete2014x‐linkedhypohidroticectodermal pages 1-2, fete2014x‐linkedhypohidroticectodermal pages 2-4) - Suggested HPO: HP:0001006 (Hypotrichosis), HP:0000535 (Sparse eyebrow)
4) Recurrent respiratory/nasal complications - Type: symptoms/clinical signs - Frequency (international patient registry, males): foul-smelling nasal discharge 67%, infections requiring antibiotics 52%, recurrent pneumonias 19%, wheeze 66%, recurrent sinusitis 49%, raspy/hoarse voice 67%. (fete2014x‐linkedhypohidroticectodermal pages 2-4) - Suggested HPO: HP:0002789 (Recurrent respiratory infections), HP:0001742 (Chronic sinusitis), HP:0002099 (Wheezing), HP:0001609 (Hoarse voice), HP:0011950 (Nasal discharge)
5) Eczema / dry skin - Type: clinical sign - Frequency (EDIR): eczema reported in 66% males and 40% females in registry summary excerpt. (fete2014x‐linkedhypohidroticectodermal pages 1-2) - Suggested HPO: HP:0000964 (Eczema), HP:0000958 (Dry skin)
6) Ocular surface disease / dry eye - Type: symptom/clinical sign - Frequency: “nearly one-third” affected with ocular dry eye in registry excerpt. (fete2014x‐linkedhypohidroticectodermal pages 2-4) - Suggested HPO: HP:0001097 (Dry eye), HP:0000508 (Photophobia) (frequently associated per ocular review context) (callea2022extendedoverviewof pages 2-4)
Quality of life is substantially impacted through heat avoidance/thermoregulation constraints, need for long-term dental rehabilitation, recurrent ENT/respiratory issues, and ocular surface disease requiring surveillance and ongoing supportive care. (aftab2023xlinkedhypohidroticectodermal pages 8-9, callea2022extendedoverviewof pages 2-4, fete2014x‐linkedhypohidroticectodermal pages 2-4)
Variant classes: deletions, nonsense, frameshift, splice-site, and missense variants affecting key functional domains (furin cleavage site, TNF homology domain, collagen-like repeats) correlate with absent versus residual sweating. (schneider2011sweatingabilityand pages 5-10)
Genotype–phenotype mapping (example evidence): missense variants disrupting the furin recognition site (R153C/R155C/R156H) and certain TNF-domain mutations (e.g., Y304C) are linked to anhidrosis, whereas some variants (e.g., V262F, R276C, G299R, R69L) can be associated with residual sweating. (schneider2011sweatingabilityand pages 5-10)
Female heterozygotes can have clinically significant symptoms with high variability (variable expressivity). (fete2014x‐linkedhypohidroticectodermal pages 2-4)
Evidence for specific modifier genes was not identified in the retrieved sources; however, the 2024 Korean cohort emphasizes that phenotype (complete triad vs incomplete) strongly predicts detection of EDA/EDAR mutations, suggesting clinical heterogeneity may partly reflect genetic heterogeneity and structural variants (CNVs). (kim2024geneticprofilingand pages 7-8, kim2024geneticprofilingand pages 1-2)
Explicit epigenetic mechanisms for XLHED were not identified in the retrieved sources.
Large deletions/CNVs affecting EDA contribute to disease and can be missed without CNV-aware analysis (e.g., MLPA/WGS). In the 2024 Korean ED cohort, 23.1% (3/13) of EDA-positive cases had CNVs. (kim2024geneticprofilingand pages 1-2)
No specific toxin/lifestyle/infectious causal factors were identified; the disease is primarily genetic. Key environmental management issue is heat exposure, which is clinically dangerous in anhidrotic patients. (schneider2018prenatalcorrectionof pages 1-2)
1) Upstream trigger: germline pathogenic EDA variant → deficiency of functional EDA1 ligand. (schneider2018prenatalcorrectionof pages 1-2) 2) Signal transduction: EDA1 binds EDAR, recruits EDARADD, and activates a TNF-like signaling cascade culminating in NF-κB activation. (callea2022extendedoverviewof pages 2-4) 3) Developmental consequence: impaired epithelial–mesenchymal signaling in placodes → failed/aborted development of ectodermal appendages (eccrine sweat glands, teeth, hair follicles, meibomian glands). (callea2022extendedoverviewof pages 2-4, schneider2018prenatalcorrectionof pages 1-2) 4) Clinical manifestations: anhidrosis/hypohidrosis → heat intolerance/hyperthermia risk; hypodontia/oligodontia → chewing/speech/esthetic impacts; hypotrichosis; frequent ENT/respiratory problems likely related to glandular/epithelial abnormalities. (fete2014x‐linkedhypohidroticectodermal pages 2-4, schneider2018prenatalcorrectionof pages 1-2)
Human eccrine sweat gland morphogenesis has a defined fetal window: “key developmental events” occur in gestational weeks 20–30, motivating prenatal replacement therapy to rescue sweat gland formation. (schneider2022ectodermaldysplasiasnew pages 2-4)
Mechanistic synthesis from recent literature indicates reciprocal reinforcement between EDA–EDAR–NF-κB signaling and WNT/β-catenin activity during placode development (e.g., Wnt10b as an NF-κB target; Wnt signaling upregulating Edar). This is commonly inferred from mouse developmental and single-cell analyses and provides a plausible mechanism linking EDA deficiency to broader appendage patterning defects. (jakhar2025interplaybetweenedaedar pages 5-7, jakhar2025interplaybetweenedaedar pages 2-4)
(These are ontology suggestions aligned with the mechanisms described in the cited sources. (callea2022extendedoverviewof pages 2-4, schneider2022ectodermaldysplasiasnew pages 2-4, jakhar2025interplaybetweenedaedar pages 2-4))
Not specifically addressed in the retrieved sources beyond EDA being a transmembrane TNF-family ligand that is cleaved and released (a secreted signaling moiety). (schneider2022ectodermaldysplasiasnew pages 2-4)
Clinical manifestations often begin in infancy/early childhood; one clinical summary reports symptom onset between “one month to 23 months.” (aftab2023xlinkedhypohidroticectodermal pages 1-2)
The disease is lifelong; some severe early-life risks (hyperthermia) can be mitigated with recognition and management. Registry data describe “life-long XLHED clinical complications” such as sinus infections, eczema, wheezing, and hoarse voice. (fete2014x‐linkedhypohidroticectodermal pages 1-2)
Predominantly X-linked (males more severely affected; females variably affected). (aftab2023xlinkedhypohidroticectodermal pages 1-2, fete2014x‐linkedhypohidroticectodermal pages 2-4)
Expert interpretation: the very large difference between molecularly confirmed prevalence and broader algorithm-defined HED prevalence implies substantial under-confirmation (genetic testing gaps) and/or misclassification when relying on administrative codes alone, supporting current emphasis on molecular confirmation and CNV-aware testing. (nguyennielsen2013theprevalenceof pages 1-2, kim2024geneticprofilingand pages 1-2)
Diagnosis is often based on the triad (sweat, hair, teeth) and characteristic facies/complications. (fete2014x‐linkedhypohidroticectodermal pages 1-2, aftab2023xlinkedhypohidroticectodermal pages 1-2)
Pilocarpine-induced sweat testing plus sweat pore density assessment is a quantifiable biomarker approach. - In Schneider et al. (2011), sweat pore count sensitivity for identifying affected males was 94% in children and 92% in adults, with clear quantitative separation from controls. (schneider2011sweatingabilityand pages 5-10) - Controls showed mean sweat volume 72 µL and mean sweat pore density 455 pores/cm², whereas many XLHED males had absent pores and 0 sweat, and low-sweating males produced 1–11 µL. (schneider2011sweatingabilityand pages 5-10, schneider2011sweatingabilityand pages 1-5)
2024 cohort evidence (Korea, Orphanet J Rare Dis; published 2024-09-?? per journal issue metadata): - Overall diagnostic yield: 74.1% (20/27) mutation-positive. (kim2024geneticprofilingand pages 1-2) - Among positives, 80% (16/20) had EDA or EDAR mutations; 23.1% (3/13) of EDA-positive cases had CNVs. (kim2024geneticprofilingand pages 1-2) - Phenotype predicts yield: 94.1% of patients with the complete triad (hair/skin/dental) had detectable EDA/EDAR mutations, vs 0% when those three symptoms were not all present. (kim2024geneticprofilingand pages 7-8, kim2024geneticprofilingand pages 1-2)
Direct abstract quote (diagnostic strategy conclusion): “When conducting molecular diagnostics for ED, opting for targeted sequencing of EDA/EDAR mutations is advisable for cases with classical symptoms, while WES is deemed an effective strategy for cases in which these symptoms are absent.” (kim2024geneticprofilingand pages 1-2)
Prenatal ultrasound-based tooth germ counting can support non-invasive fetal assessment in at-risk pregnancies; this approach is used in trial screening and was part of the diagnostic workup for prenatal therapy. (schneider2022ectodermaldysplasiasnew pages 1-2, schneider2018prenatalcorrectionof pages 1-2)
A case-based review highlights the need to distinguish XLHED from other ectodermal dysplasias and syndromes (e.g., EEC syndrome) and acquired hypohidrosis causes, emphasizing clinical and molecular confirmation. (aftab2023xlinkedhypohidroticectodermal pages 8-9)
In EDIR registry analysis, 21% of XLHED registrants reported a family history of infant or childhood deaths, stated as consistent with published mortality data. (fete2014x‐linkedhypohidroticectodermal pages 1-2)
Current routine care is largely supportive and preventive, including thermoregulation/heat avoidance strategies, dental rehabilitation (prosthodontics/implants), dermatologic management (eczema/dry skin), ENT/pulmonary management for recurrent infections, and ophthalmic care for dry eye/ocular surface disease. (aftab2023xlinkedhypohidroticectodermal pages 8-9, callea2022extendedoverviewof pages 2-4)
Suggested MAXO terms (examples): supportive care; dental prosthesis placement; management of hyperthermia; skin emollient therapy; artificial tears / ocular surface lubrication; respiratory infection prevention.
Schneider et al. (NEJM, 2018-04-26) reported intra-amniotic administration of Fc-EDA (EDI200) to 3 affected male fetuses. - Dosing (twins): 100 mg/kg estimated fetal body weight at gestational week 26 and again at week 31. (schneider2018prenatalcorrectionof pages 3-5) - Evidence of fetal uptake: cord-blood Fc-EDA measurable 7 days after administration (62.4 and 932 ng/mL). (schneider2018prenatalcorrectionof pages 3-5) - Efficacy endpoints: treated infants had normal sweat-duct density and “normal pilocarpine-induced sweating at 6 months,” with no hyperthermic episodes or respiratory-related hospitalizations over 22 months in the twin case. (schneider2018prenatalcorrectionof pages 3-5) - Quote (author conclusion): “Prenatal treatment with Fc-EDA restored sustained sweating ability in human patients with EDA mutations that abrogate perspiration.” (schneider2018prenatalcorrectionof pages 5-7)
Visual evidence: Figure 1 from the NEJM report shows the contrast between untreated XLHED (no sweat pores/0 µL sweat) and treated infant vs healthy control for sweat pores and sweat volume outcomes. (schneider2018prenatalcorrectionof media 9c02cda0)
A translational review notes that postnatal dosing in infants did not successfully induce sweat ducts or sweating, consistent with a restricted developmental window for eccrine gland morphogenesis. (schneider2022ectodermaldysplasiasnew pages 2-4)
ClinicalTrials.gov describes ER004 as an “EDA1 replacement” designed for high-affinity EDAR binding. - Design: Phase 2, open-label, genotype-match controlled; 3 intra-amniotic injections ~3 weeks apart starting gestational week 26 at 100 mg/kg estimated fetal weight per injection. (NCT04980638 chunk 1) - Primary endpoint: mean sweat volume at 6 months (pilocarpine-induced). (NCT04980638 chunk 1) - Secondary endpoints include: sweat pore density, dental development, meibomian glands, ocular outcomes, hospitalizations for hyperthermia/infections. (NCT04980638 chunk 1)
Expert analysis: the trial’s inclusion of objective sweating endpoints (sweat volume and pore density) and longer follow-up (to age 5) directly addresses prior limitations of early small compassionate-use series and aligns with validated sweat biomarkers (pilocarpine iontophoresis, pore counts) used in genotype–phenotype work. (NCT04980638 chunk 1, schneider2011sweatingabilityand pages 5-10)
No primary prevention exists for germline XLHED beyond reproductive options.
Key complication prevention includes early diagnosis, anticipatory guidance for fever/heat exposure, and early dental/ENT/ophthalmic interventions to prevent downstream morbidity. (aftab2023xlinkedhypohidroticectodermal pages 8-9, callea2022extendedoverviewof pages 2-4)
Given X-linked inheritance and severe male phenotype, cascade testing and counseling are central. Prenatal ultrasound screening (tooth germ assessment) is used clinically and in trial screening as a non-invasive diagnostic tool in at-risk pregnancies. (schneider2022ectodermaldysplasiasnew pages 1-2, schneider2018prenatalcorrectionof pages 1-2)
Naturally occurring EDA-related hypohidrotic ectodermal dysplasia has been reported across species, supporting conserved biology. - Cat (first report, 2024-06): a male cat with alopecia and tooth anomalies had a hemizygous EDA missense variant; the paper notes EDA loss-of-function variants cause HED in humans, mice, dogs, and cattle and extends this to cats. (rietmann2024edamissensevariant pages 1-2) - Cattle (historic): evidence cited for bovine anhidrotic ED caused by deletion of exon 3 of the bovine ED1 gene (EDA ortholog). (rietmann2024edamissensevariant pages 2-4)
NCBI Taxonomy identifiers were not provided in the retrieved excerpts.
The Tabby mouse is a canonical model of EDA deficiency used to study ectodermal appendage development and therapeutic rescue by prenatal EDA replacement; mechanistic work in the NEJM report also used Eda-deficient mice to show neonatal Fc receptor–dependent fetal uptake after intra-amniotic therapy. (schneider2018prenatalcorrectionof pages 2-3, schneider2018prenatalcorrectionof pages 3-5)
Dog models of XLHED have been used for prenatal recombinant EDA1 administration, with improvements reported across multiple ectodermal structures, supporting translational relevance to prenatal therapy. (aftab2023xlinkedhypohidroticectodermal pages 8-9)
References
(aftab2023xlinkedhypohidroticectodermal pages 1-2): Hammad Aftab, Ivan A Escudero, and Fatin Sahhar. X-linked hypohidrotic ectodermal dysplasia (xlhed): a case report and overview of the diagnosis and multidisciplinary modality treatments. Cureus, Jun 2023. URL: https://doi.org/10.7759/cureus.40383, doi:10.7759/cureus.40383. This article has 10 citations.
(callea2022extendedoverviewof pages 2-4): Michele Callea, Stefano Bignotti, Francesco Semeraro, Francisco Cammarata-Scalisi, Jinia El-Feghaly, Antonino Morabito, Vito Romano, and Colin E. Willoughby. Extended overview of ocular phenotype with recent advances in hypohidrotic ectodermal dysplasia. Children, 9:1357, Sep 2022. URL: https://doi.org/10.3390/children9091357, doi:10.3390/children9091357. This article has 9 citations.
(kim2024geneticprofilingand pages 1-2): Man Jin Kim, Jee-Soo Lee, Seung Won Chae, Sung Im Cho, Jangsup Moon, Jung Min Ko, Jong-Hee Chae, and Moon-Woo Seong. Genetic profiling and diagnostic strategies for patients with ectodermal dysplasias in korea. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03331-6, doi:10.1186/s13023-024-03331-6. This article has 1 citations and is from a peer-reviewed journal.
(kim2024geneticprofilingand pages 7-8): Man Jin Kim, Jee-Soo Lee, Seung Won Chae, Sung Im Cho, Jangsup Moon, Jung Min Ko, Jong-Hee Chae, and Moon-Woo Seong. Genetic profiling and diagnostic strategies for patients with ectodermal dysplasias in korea. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03331-6, doi:10.1186/s13023-024-03331-6. This article has 1 citations and is from a peer-reviewed journal.
(schneider2018prenatalcorrectionof pages 3-5): Holm Schneider, Florian Faschingbauer, Sonia Schuepbach-Mallepell, Iris Körber, Sigrun Wohlfart, Angela Dick, Mandy Wahlbuhl, Christine Kowalczyk-Quintas, Michele Vigolo, Neil Kirby, Corinna Tannert, Oliver Rompel, Wolfgang Rascher, Matthias W. Beckmann, and Pascal Schneider. Prenatal correction of x-linked hypohidrotic ectodermal dysplasia. New England Journal of Medicine, 378:1604-1610, Apr 2018. URL: https://doi.org/10.1056/nejmoa1714322, doi:10.1056/nejmoa1714322. This article has 219 citations and is from a highest quality peer-reviewed journal.
(NCT04980638 chunk 1): Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia. EspeRare Foundation. 2022. ClinicalTrials.gov Identifier: NCT04980638
(fete2014x‐linkedhypohidroticectodermal pages 2-4): Mary Fete, Julie Hermann, Jeffrey Behrens, and Kenneth M. Huttner. X‐linked hypohidrotic ectodermal dysplasia (xlhed): clinical and diagnostic insights from an international patient registry. American Journal of Medical Genetics Part A, 164:2437-2442, Oct 2014. URL: https://doi.org/10.1002/ajmg.a.36436, doi:10.1002/ajmg.a.36436. This article has 72 citations.
(fete2014x‐linkedhypohidroticectodermal pages 1-2): Mary Fete, Julie Hermann, Jeffrey Behrens, and Kenneth M. Huttner. X‐linked hypohidrotic ectodermal dysplasia (xlhed): clinical and diagnostic insights from an international patient registry. American Journal of Medical Genetics Part A, 164:2437-2442, Oct 2014. URL: https://doi.org/10.1002/ajmg.a.36436, doi:10.1002/ajmg.a.36436. This article has 72 citations.
(NCT04980638 chunk 2): Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia. EspeRare Foundation. 2022. ClinicalTrials.gov Identifier: NCT04980638
(nguyennielsen2013theprevalenceof pages 1-2): Mary Nguyen-Nielsen, Stine Skovbo, Dea Svaneby, Lars Pedersen, and Jon Fryzek. The prevalence of x-linked hypohidrotic ectodermal dysplasia (xlhed) in denmark, 1995-2010. European journal of medical genetics, 56 5:236-42, May 2013. URL: https://doi.org/10.1016/j.ejmg.2013.01.012, doi:10.1016/j.ejmg.2013.01.012. This article has 97 citations and is from a peer-reviewed journal.
(schneider2018prenatalcorrectionof pages 1-2): Holm Schneider, Florian Faschingbauer, Sonia Schuepbach-Mallepell, Iris Körber, Sigrun Wohlfart, Angela Dick, Mandy Wahlbuhl, Christine Kowalczyk-Quintas, Michele Vigolo, Neil Kirby, Corinna Tannert, Oliver Rompel, Wolfgang Rascher, Matthias W. Beckmann, and Pascal Schneider. Prenatal correction of x-linked hypohidrotic ectodermal dysplasia. New England Journal of Medicine, 378:1604-1610, Apr 2018. URL: https://doi.org/10.1056/nejmoa1714322, doi:10.1056/nejmoa1714322. This article has 219 citations and is from a highest quality peer-reviewed journal.
(nguyennielsen2013theprevalenceof pages 2-3): Mary Nguyen-Nielsen, Stine Skovbo, Dea Svaneby, Lars Pedersen, and Jon Fryzek. The prevalence of x-linked hypohidrotic ectodermal dysplasia (xlhed) in denmark, 1995-2010. European journal of medical genetics, 56 5:236-42, May 2013. URL: https://doi.org/10.1016/j.ejmg.2013.01.012, doi:10.1016/j.ejmg.2013.01.012. This article has 97 citations and is from a peer-reviewed journal.
(schneider2022ectodermaldysplasiasnew pages 1-2): Holm Schneider. Ectodermal dysplasias: new perspectives on the treatment of so far immedicable genetic disorders. Frontiers in Genetics, Sep 2022. URL: https://doi.org/10.3389/fgene.2022.1000744, doi:10.3389/fgene.2022.1000744. This article has 27 citations and is from a peer-reviewed journal.
(kovalskaia2023molecularbasisand pages 1-2): V. A. Kovalskaia, T. Cherevatova, A. V. Polyakov, and O. P. Ryzhkova. Molecular basis and genetics of hypohidrotic ectodermal dysplasias. Vavilov Journal of Genetics and Breeding, 27:676-683, Nov 2023. URL: https://doi.org/10.18699/vjgb-23-78, doi:10.18699/vjgb-23-78. This article has 6 citations.
(schneider2011sweatingabilityand pages 5-10): Holm Schneider, Johanna Hammersen, Sabine Preisler-Adams, Kenneth Huttner, Wolfgang Rascher, and Axel Bohring. Sweating ability and genotype in individuals with x-linked hypohidrotic ectodermal dysplasia. Journal of Medical Genetics, 48:426-432, Feb 2011. URL: https://doi.org/10.1136/jmg.2010.084012, doi:10.1136/jmg.2010.084012. This article has 70 citations and is from a domain leading peer-reviewed journal.
(schneider2011sweatingabilityand pages 1-5): Holm Schneider, Johanna Hammersen, Sabine Preisler-Adams, Kenneth Huttner, Wolfgang Rascher, and Axel Bohring. Sweating ability and genotype in individuals with x-linked hypohidrotic ectodermal dysplasia. Journal of Medical Genetics, 48:426-432, Feb 2011. URL: https://doi.org/10.1136/jmg.2010.084012, doi:10.1136/jmg.2010.084012. This article has 70 citations and is from a domain leading peer-reviewed journal.
(aftab2023xlinkedhypohidroticectodermal pages 8-9): Hammad Aftab, Ivan A Escudero, and Fatin Sahhar. X-linked hypohidrotic ectodermal dysplasia (xlhed): a case report and overview of the diagnosis and multidisciplinary modality treatments. Cureus, Jun 2023. URL: https://doi.org/10.7759/cureus.40383, doi:10.7759/cureus.40383. This article has 10 citations.
(schneider2022ectodermaldysplasiasnew pages 2-4): Holm Schneider. Ectodermal dysplasias: new perspectives on the treatment of so far immedicable genetic disorders. Frontiers in Genetics, Sep 2022. URL: https://doi.org/10.3389/fgene.2022.1000744, doi:10.3389/fgene.2022.1000744. This article has 27 citations and is from a peer-reviewed journal.
(jakhar2025interplaybetweenedaedar pages 5-7): Ajay Jakhar, Konrad Łukaszyk, Anna Pulawska-Czub, and Krzysztof Kobielak. Interplay between eda-edar and wnt signalling pathways in the development of skin appendages in hypohidrotic ectodermal dysplasia. Pediatria i Medycyna Rodzinna, 21:51-58, Apr 2025. URL: https://doi.org/10.15557/pimr.2025.0006, doi:10.15557/pimr.2025.0006. This article has 3 citations.
(jakhar2025interplaybetweenedaedar pages 2-4): Ajay Jakhar, Konrad Łukaszyk, Anna Pulawska-Czub, and Krzysztof Kobielak. Interplay between eda-edar and wnt signalling pathways in the development of skin appendages in hypohidrotic ectodermal dysplasia. Pediatria i Medycyna Rodzinna, 21:51-58, Apr 2025. URL: https://doi.org/10.15557/pimr.2025.0006, doi:10.15557/pimr.2025.0006. This article has 3 citations.
(schneider2018prenatalcorrectionof pages 5-7): Holm Schneider, Florian Faschingbauer, Sonia Schuepbach-Mallepell, Iris Körber, Sigrun Wohlfart, Angela Dick, Mandy Wahlbuhl, Christine Kowalczyk-Quintas, Michele Vigolo, Neil Kirby, Corinna Tannert, Oliver Rompel, Wolfgang Rascher, Matthias W. Beckmann, and Pascal Schneider. Prenatal correction of x-linked hypohidrotic ectodermal dysplasia. New England Journal of Medicine, 378:1604-1610, Apr 2018. URL: https://doi.org/10.1056/nejmoa1714322, doi:10.1056/nejmoa1714322. This article has 219 citations and is from a highest quality peer-reviewed journal.
(schneider2018prenatalcorrectionof media 9c02cda0): Holm Schneider, Florian Faschingbauer, Sonia Schuepbach-Mallepell, Iris Körber, Sigrun Wohlfart, Angela Dick, Mandy Wahlbuhl, Christine Kowalczyk-Quintas, Michele Vigolo, Neil Kirby, Corinna Tannert, Oliver Rompel, Wolfgang Rascher, Matthias W. Beckmann, and Pascal Schneider. Prenatal correction of x-linked hypohidrotic ectodermal dysplasia. New England Journal of Medicine, 378:1604-1610, Apr 2018. URL: https://doi.org/10.1056/nejmoa1714322, doi:10.1056/nejmoa1714322. This article has 219 citations and is from a highest quality peer-reviewed journal.
(rietmann2024edamissensevariant pages 1-2): Stefan J. Rietmann, Noëlle Cochet-Faivre, Helene Dropsy, Vidhya Jagannathan, Lucie Chevallier, and Tosso Leeb. Eda missense variant in a cat with x-linked hypohidrotic ectodermal dysplasia. Genes, 15:854, Jun 2024. URL: https://doi.org/10.3390/genes15070854, doi:10.3390/genes15070854. This article has 1 citations.
(rietmann2024edamissensevariant pages 2-4): Stefan J. Rietmann, Noëlle Cochet-Faivre, Helene Dropsy, Vidhya Jagannathan, Lucie Chevallier, and Tosso Leeb. Eda missense variant in a cat with x-linked hypohidrotic ectodermal dysplasia. Genes, 15:854, Jun 2024. URL: https://doi.org/10.3390/genes15070854, doi:10.3390/genes15070854. This article has 1 citations.
(schneider2018prenatalcorrectionof pages 2-3): Holm Schneider, Florian Faschingbauer, Sonia Schuepbach-Mallepell, Iris Körber, Sigrun Wohlfart, Angela Dick, Mandy Wahlbuhl, Christine Kowalczyk-Quintas, Michele Vigolo, Neil Kirby, Corinna Tannert, Oliver Rompel, Wolfgang Rascher, Matthias W. Beckmann, and Pascal Schneider. Prenatal correction of x-linked hypohidrotic ectodermal dysplasia. New England Journal of Medicine, 378:1604-1610, Apr 2018. URL: https://doi.org/10.1056/nejmoa1714322, doi:10.1056/nejmoa1714322. This article has 219 citations and is from a highest quality peer-reviewed journal.